Effect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong

Int J Antimicrob Agents. 2011 Mar;37(3):270-1. doi: 10.1016/j.ijantimicag.2010.11.016. Epub 2011 Jan 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ceftazidime / blood
  • Ceftazidime / pharmacology*
  • Ceftazidime / urine
  • Ceftriaxone / blood
  • Ceftriaxone / pharmacology*
  • Ceftriaxone / urine
  • Escherichia coli / drug effects*
  • Escherichia coli / enzymology
  • Escherichia coli / isolation & purification
  • Hong Kong
  • Humans
  • Microbial Sensitivity Tests
  • beta-Lactam Resistance
  • beta-Lactamases / metabolism

Substances

  • Ceftriaxone
  • Ceftazidime
  • beta-lactamase TEM-3
  • beta-Lactamases